Evelyn Bradley

Evelyn Bradley serves as a Contract Specialist (CTR) responsible for managing the full lifecycle of federal acquisitions within a specialized technical domain. Her role involves developing solicitation documents, conducting market research, evaluating proposals, and administering contracts in compliance with the Federal Acquisition Regulation (FAR) and agency-specific policies. She plays a critical part in ensuring timely and lawful procurement of high-priority biological products, aligning acquisition strategies with mission-critical public health and scientific objectives. Her portfolio is exclusively focused on complex, regulated manufacturing contracts requiring rigorous technical and regulatory oversight. Evelyn collaborates with a diverse range of contractors specializing in the development and production of biological products, including biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and regulated supply chain vendors. While no single contractor dominates her portfolio, her procurement patterns reflect consistent engagement with firms possessing current Good Manufacturing Practices (cGMP) certifications and FDA-registered facilities. She fosters collaborative relationships grounded in compliance, performance accountability, and risk mitigation, ensuring contract execution meets stringent quality and safety standards. Evelyn’s contracting activity is entirely non-set-aside, with 100% of her awards issued under full and open competition. This reflects a strategic alignment with the technical complexity and scale of biological product manufacturing, where specialized capabilities and regulatory compliance often necessitate broad market participation. While she does not prioritize socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs, her approach ensures that all eligible vendors—regardless of size—compete on a level playing field based on technical merit and regulatory readiness. Her primary procurement focus is on NAICS 325414, Biological Product (except Diagnostic) Manufacturing, encompassing vaccines, therapeutic biologics, cell and gene therapies, and related bulk drug substances. She possesses deep expertise in the regulatory and manufacturing frameworks governing these products, including FDA oversight, process validation, and cold chain logistics. Her acquisitions support national health security, clinical research, and public health preparedness initiatives, requiring precise alignment with scientific and manufacturing standards.